CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study

• Shunsuke Hamada,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Naohisa Futamura,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Kunihiro Ikuta,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Hiroshi Urakawa,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Eiji Kozawa,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Naoki Ishiguro,

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯
• Yoshihiro Nishida

  * E-mail: ynishida@med.nagoya-u.ac.jp

  Affiliation Department of Orthopaedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan

  ⨯